NuvaRing Discontinuation Rate Raises Questions

December 2, 2012

NuvaRing, a heavily marketed and widely distributed contraceptive vaginal ring, was approved by the Food and Drug Administration (FDA) in 2001 and is used by more than 1,000,000 women worldwide. Recent studies, however, suggest that NuvaRing’s benefits are not without potentially serious side effects.


NuvaRing patients in two clinical studies discontinued NuvaRing use at a rate of just over 15 percent, citing adverse events. While some adverse events are relatively minor, like headaches, others are more serious. In fact, some patients have experienced cardiovascular issues such as stroke and heart attack.


Want to know more about the legal consequences of your NuvaRing adverse events? The attorneys at the Dallas law firm of Fears Nachawati are prepared to answer your questions and advise you and your family on your potential next steps. For your free consultation, call us at 1.866.545.8364 or email

More Blog Posts


Use the form below to send us a note, call us at 214.890.0711, or chat with us live. We are eager to help you. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law


With offices in Texas, Florida, and Colorado, and attorneys licensed in Texas, Florida, Colorado, Arkansas, and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We are creative, empathetic, and reliable professionals.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consultation

Live Chat (Online Now)